Following the growth of Liberi Group, especially in the Asian market, we are proud to announce the appointment of Tim Chang as Head of Asian Operations. With a thorough understanding …

Head of Asian Operations Read More »

PARIS, & MONTPELIER, FRANCE, 1st August 2022 – Ipsen (Euronext: IPN; ADR: IPSEY) and AGV Discovery today announced that Ipsen has exercised its option to acquire exclusive worldwide rights to an investigational ERK …

Ipsen to acquire exclusive rights to investigational ERK inhibitor as part of its existing research collaboration with AGV Discovery Read More »

We are proud to officially announce that Simon Dabekaussen, former Corporate Development manager at Liberi Group, has been appointed Chief Operating Officer. Liberi Group’s shareholders decided to appoint a candidate …

Chief Operating Officer Read More »

Over the last 10 years Liberi Group has been successful in making deals for biotech companies with both Strategic Pharma and Investors, all on a global or regional level. Even …

Liberi Group opens up database for Rare Diseases Read More »